<DOC>
	<DOC>NCT01724242</DOC>
	<brief_summary>There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.</brief_summary>
	<brief_title>Vaginal DHEA for Women After Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>women post menopausal aged 3555, suffering from vaginal dryness, secondary to chemotherapy for breast cancer, within 5 years of diagnosis. Follicle Stimulating Hormone and Estradiol levels in the post menopausal range are needed. women using products to alleviate vaginal dryness. women taking medication for urinary incontinence women not sexually active, for other reasons.</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Vaginal dryness</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Urinary Incontinence</keyword>
	<keyword>Quality of Life</keyword>
	<keyword>Sexual Satisfaction</keyword>
</DOC>